Gemini’s Canvas now auto-generates full slide decks from a prompt or uploaded source, with themes and images, and exports to ...
Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...
NEXICART-2 (NCT06097832) is an ongoing multi-site U.S. Phase 1/2 clinical trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory AL Amyloidosis, with a registrational design. Interim ...
ZDNET's key takeaways Google Gemini can now create a slide show presentation for you.You can base the presentation on a text ...
Oral presentation Sunday, December 7, at ASH 2025 - LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), the global leader in relapsed/ ...
Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ ...
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a company focused on advancing innovative ...
Canva has launched its own AI design model, expanded its assistant, and integrated data tools and marketing features, while making its Affinity professional design suite free for all users.
CapCut introduces AI-powered design gear, inclusive of an AI logo generator and transparent historical past maker, increasing its platform past video editing to help integrate logo identity ...
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and update SOUTH SAN FRANCISCO, CA / ACCESS Newswire / ...
Affinity now connects with Canva’s AI Studio, integrating tools such as Generative Fill, Expand & Edit, and Remove Background ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback